More than 1,200 independent oncology clinics have shut down or been acquired by a hospital since 2018, according to new data from the Community Oncology Alliance—and oncologists say Medicare's 340B drug discount program and sequester-related cuts to Medicare Part B are driving the trend, Susannah Luthi reports for Modern Healthcare.
Data highlight clinic closures
The Community Oncology Alliance data show that, since 2008:
- 658 independent oncology clinics have been acquired by or entered into contracts with hospitals;
- 423 clinics have closed; and
- 168 clinics have been acquired by or merged with other practices.
The alliance said Florida, Michigan, and Texas have seen the highest numbers of clinic closures.
Clinics say federal policies are to blame
Some clinics have said federal sequester cuts to Medicare Part B reimbursements are partly to blame, noting that the cuts in certain instances have caused them to send their Medicare patients elsewhere for chemotherapy.
In addition, the alliance said more hospitals sought to bring cancer care in-house to qualify for the 340B program's discounts. The 340B program requires drug manufacturers to provide outpatient drugs to eligible health care providers at discounts ranging from 20% to 50%. According to the Medicare Payment Advisory Commission, 45% of acute care hospitals are eligible for the program, but independent oncology clinics are not.
According to Luthi, many oncologists say they're at risk of acquisition by 340B hospitals because of the discounts the hospitals get on cancer drugs. "The [oncology] practices are in a tough, delicate situation," said Ted Okon, president of the Community Oncology Alliance.
In Florida and Texas, many independent oncology clinics have merged to avoid being acquired by hospitals, Luthi reports. According to Okon, oncologist consolidation was responsible for about 50 clinic closures in Florida and 43 in Texas.
But in Michigan, cancer doctors turned to hospitals as rural independent oncology clinics closed. According to Okon, the Michigan trend might have been spurred by hospitals seeking to expand their services to include cancer treatment. "A hospital is typically constructing some big building, and that's why they want cancer care to go to their operating sites that are losing money or just barely breaking even."
Some clinics could fight back
To stem closures among independent oncology clinics, Okon said lawmakers should support more robust reporting requirements for the 340B program and roll-back sequester cuts to Part B reimbursements.
But Okon also suggested that oncology groups might take matters into their own hands and sue the federal government to restore Medicare Part B payments. "We are at the end of the rope," he said (Luthi, Modern Healthcare, 4/30).
Medicare 101: Cheat sheets for Parts A through D
Through the years Medicare has grown more complicated, including private supplemental insurance and prescription drug coverage. Download our cheat sheets to learn how each of the four parts of Medicare works, and why they’re so important for provider organizations: